Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A effects on detrusor contractility in overactive bladder
NL-OMON31265Phase 4Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in overactive bladder (OAB) and urinary incontinence (UI), sponsored by University Medical Center Groningen. Primary endpoint: Change in detrusor contractility after botulinum toxin A treatment. Planned start Oct 2007; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on NL-OMON31265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31265.